Effect of kava ( Piper methysticum ) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7999 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Lachlan Cribb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Professorial Unit, The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Kava, Anti-Anxiety Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: National Health and Medical Research Council, Integria Healthcare, NHMRC Clinical Research Fellowship.
Abstract (Originalsprache)
Kava is a South Pacific plant‐based medicine with anxiolytic properties, but little is known about the impact kava has on gene expression or whether gene expression can serve as a marker of kava response. This study aimed to determine whether kava treatment alters the expression of genes with physiological relevance to anxiety pathophysiology and whether the baseline expression of these physiologically relevant genes modifies the efficacy of kava treatment. In this post hoc analysis, we examined the expression of 48 genes relevant to the pathophysiology of anxiety collected from a double‐blind randomized controlled trial that assessed the efficacy of kava treatment in generalized anxiety disorder. Peripheral blood gene expression was measured in 71 (34 kava, 37 placebo) adults at baseline and in 40 (19 kava, 21 placebo) after 8 weeks of treatment by reverse transcription polymerase chain reaction (PCR). Results revealed that kava decreased the expression of a subunit of the GABA A ‐rho receptor gene (GABRR2) and catechol‐O‐methyltransferase (COMT), a gene related to catecholamine metabolism. Kava efficacy was not found to be modified by baseline (pretreatment) expression of relevant genes. Although these results did not withstand statistical correction for multiple comparisons and require external validation, they support the notion that kava's mechanism of action includes interaction with GABAergic and catecholaminergic systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Professorial Unit, The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia.
- NICM Health Research Institute, Western Sydney University, Westmead, New South Wales, Australia.
- Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Psychiatry, ACT Health, Canberra, Australia.
- School of Clinical Medicine, Discipline of Psychiatry, The University of Queensland, Queensland, Australia.
- Centre for Human Psychopharmacology, Hawthorn, Swinburne University of Technology, Victoria, Australia.
ORCID-Profile: Lachlan Cribb, Jerome Sarris, Karen M Savage
Förderung
- National Health and Medical Research Council
- Integria Healthcare
- NHMRC Clinical Research Fellowship
Zitieren
APA
Cribb, L., Sarris, J., Savage, K. M., Byrne, G. J., Metri, N. J., Scholey, A., Stough, C., & Bousman, C. A. (2023). Effect of kava ( Piper methysticum ) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial. Phytotherapy Research. https://doi.org/10.1002/ptr.7999
Vancouver
Cribb L, Sarris J, Savage KM, Byrne GJ, Metri NJ, Scholey A, et al. Effect of kava ( Piper methysticum ) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial. Phytotherapy Research. 2023. doi:10.1002/ptr.7999
BibTeX
@article{Cribb2023,
author = {Cribb, Lachlan and Sarris, Jerome and Savage, Karen M and Byrne, Gerard J and Metri, Najwa-Joelle and Scholey, Andrew and Stough, Con and Bousman, Chad A},
title = {Effect of kava ( Piper methysticum ) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7999}
}
EUVIMED